BE1007752A5 - Compositions pharmaceutiques de peptides et procedes pour leur preparation. - Google Patents

Compositions pharmaceutiques de peptides et procedes pour leur preparation. Download PDF

Info

Publication number
BE1007752A5
BE1007752A5 BE9200650A BE9200650A BE1007752A5 BE 1007752 A5 BE1007752 A5 BE 1007752A5 BE 9200650 A BE9200650 A BE 9200650A BE 9200650 A BE9200650 A BE 9200650A BE 1007752 A5 BE1007752 A5 BE 1007752A5
Authority
BE
Belgium
Prior art keywords
sep
pharmaceutical composition
acid
composition according
lys
Prior art date
Application number
BE9200650A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919115202A external-priority patent/GB9115202D0/en
Priority claimed from GB929200748A external-priority patent/GB9200748D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1007752A5 publication Critical patent/BE1007752A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE9200650A 1991-07-15 1992-07-13 Compositions pharmaceutiques de peptides et procedes pour leur preparation. BE1007752A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919115202A GB9115202D0 (en) 1991-07-15 1991-07-15 Improvements relating to organic compounds
GB929200748A GB9200748D0 (en) 1992-01-14 1992-01-14 Improvements relating to organic compounds

Publications (1)

Publication Number Publication Date
BE1007752A5 true BE1007752A5 (fr) 1995-10-17

Family

ID=26299234

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9200650A BE1007752A5 (fr) 1991-07-15 1992-07-13 Compositions pharmaceutiques de peptides et procedes pour leur preparation.

Country Status (7)

Country Link
JP (1) JPH05194260A (de)
BE (1) BE1007752A5 (de)
CH (1) CH685600A5 (de)
DE (1) DE4222647A1 (de)
FR (1) FR2682598B1 (de)
GB (1) GB2257908B (de)
IT (1) IT1263222B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
EP0983769A4 (de) 1997-04-14 2002-05-02 Mitsubishi Tokyo Pharm Inc Permucose formulierung
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
GB2127689A (en) * 1982-10-05 1984-04-18 Sandoz Ltd Calcitonin inhalation compositions
EP0115627A1 (de) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Steigerung der intranasalen Absorption von Calcitonin durch dessen Formulierung mit oberflächenaktiven Mitteln
FR2620331A1 (fr) * 1987-09-15 1989-03-17 Sandoz Sa Suppositoires a base de calcitonine
WO1989009786A1 (en) * 1988-04-08 1989-10-19 Sandoz Ag Peptide derivatives
GB2218098A (en) * 1988-04-30 1989-11-08 Sandoz Ltd Acid addition salts of amidated taurine or glycine, their preparation and use
EP0418642A1 (de) * 1989-09-11 1991-03-27 Teikoku Seiyaku Kabushiki Kaisha Hoch-resorbierbare transvaginale Zubereitung mit biologisch aktiven Peptiden

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
GB2127689A (en) * 1982-10-05 1984-04-18 Sandoz Ltd Calcitonin inhalation compositions
EP0115627A1 (de) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Steigerung der intranasalen Absorption von Calcitonin durch dessen Formulierung mit oberflächenaktiven Mitteln
FR2620331A1 (fr) * 1987-09-15 1989-03-17 Sandoz Sa Suppositoires a base de calcitonine
WO1989009786A1 (en) * 1988-04-08 1989-10-19 Sandoz Ag Peptide derivatives
GB2218098A (en) * 1988-04-30 1989-11-08 Sandoz Ltd Acid addition salts of amidated taurine or glycine, their preparation and use
EP0418642A1 (de) * 1989-09-11 1991-03-27 Teikoku Seiyaku Kabushiki Kaisha Hoch-resorbierbare transvaginale Zubereitung mit biologisch aktiven Peptiden

Also Published As

Publication number Publication date
FR2682598B1 (fr) 1996-04-05
ITRM920535A1 (it) 1994-01-14
JPH05194260A (ja) 1993-08-03
GB2257908A (en) 1993-01-27
DE4222647A1 (de) 1993-01-21
FR2682598A1 (fr) 1993-04-23
GB9214830D0 (en) 1992-08-26
ITRM920535A0 (it) 1992-07-14
IT1263222B (it) 1996-08-05
GB2257908B (en) 1995-12-20
CH685600A5 (de) 1995-08-31

Similar Documents

Publication Publication Date Title
EP3463295B1 (de) Zusammensetzungen in form einer injizierbaren wässrigen lösung mit menschlichem glucagon und einer endgepfropften copolyaminosäure
EP0593601B1 (de) Taxan-derivate enthaltende arzneimittel
JPS60208910A (ja) 水難溶性薬物・リン脂質複合体の製造方法
CH684192A5 (fr) Médicaments renfermant un sel de 3-(2-(diméthylamino)éthyl)-N-méthyl-1H-indole-5-méthanesulfonamide.
EP0336851A1 (de) Diphosphonsäurederivat enthaltendes Arzneimittel zur oralen Gabe
HUP0000547A2 (hu) Cinkmentes inzulinkristályok pulmonáris kompozíciókhoz
FR2754453A1 (fr) Preparations pharmaceutiques a administrer par voie nasale
FR2774591A1 (fr) Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
JPS61501775A (ja) 心臓障害の処置または予防用の医薬組成物および方法
EP0241376A1 (de) Phosphatidylinositolmannosiden enthaltende Liposome und ihre pharmazeutische Zusammensetzungen
JPH0818981B2 (ja) 水性のポンプスプレー用調剤およびその製造法
EP3720471B1 (de) Zusammensetzungen in form einer injizierbaren wässrigen lösung mit menschlichem glucagon und einer copolyaminosäure
US20030162721A1 (en) Pharmaceutical composition containing peptichemio
FR2682598A1 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
WO1995014462A1 (fr) Nouvelle composition pharmaceutique destinee a la preparation d'une poudre stable contenant, a titre d'ingredient actif, une association d'acide acetylsalicylique et de metoclopramide
MC1265A1 (fr) Preparation d'un medicament a base de prostaglandines
EP3373953B1 (de) Schnell wirkende insulinzusammensetzung mit einem substituierten citrat
FR2663227A1 (fr) Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree.
MC1379A1 (fr) Formule pharmaceutique isotonique stabilisee contenant un compose du mercure comme agent de conservation
FR2773489A1 (fr) Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
BE1001704A3 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
FR3084586A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes
EP4313155A1 (de) Orale formulierung von ivermectin und verwendungen davon
FR2623090A1 (fr) Compositions pharmaceutiques contenant une calcitonine
CA2039120C (fr) Complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19970731